03:53 PM EDT, 08/12/2025 (MT Newswires) -- Health care stocks were higher late Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.5%.

The iShares Biotechnology ETF (IBB) climbed 1.7%.

In corporate news, Eli Lilly ( LLY ) is being sued by Texas Attorney General Ken Paxton for allegedly bribing medical providers to prescribe its products, including weight loss and diabetes medications Mounjaro and Zepbound, the attorney general's office said Tuesday. Eli Lilly ( LLY ) shares were fractionally higher.

Insmed ( INSM ) shares jumped past 7% after it said Tuesday the US Food and Drug Administration has approved Brinsupri to treat non-cystic fibrosis bronchiectasis in adults and children 12 years and above.

Biogen (BIIB) Chief Executive Chris Viehbacher sees Novo Nordisk's (NVO) study evaluating its weight-loss drug for Alzheimer's disease as an opportunity to potentially create a more potent therapy, Bloomberg reported, citing the CEO. Biogen shares added 0.7%.

AbbVie ( ABBV ) said Tuesday it will invest $195 million to construct a new facility in North Chicago, Illinois, to ramp domestic active pharmaceutical ingredient manufacturing. Its shares were nearly flat.